Angiography: advantages and hazards.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 6019189)

Published in Am Heart J on March 01, 1967

Authors

J McGuire, T C Chou

Articles by these authors

(truncated to the top 100)

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul (1984) 35.22

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med (2000) 7.48

ARTERIOVENOUS ANEURYSMS. Ann Surg (1938) 6.73

RELATIONSHIP OF ACUTE INFECTIONS TO GLOMERULAR NEPHRITIS. J Clin Invest (1927) 5.40

Periarteritis Nodosa in Experimental Hypertensive Rats and Dogs. Am J Pathol (1944) 4.54

The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci (2001) 4.33

Fos expression in orexin neurons varies with behavioral state. J Neurosci (2001) 3.08

Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. Eur J Biochem (1981) 3.01

Melanopsin in cells of origin of the retinohypothalamic tract. Nat Neurosci (2001) 2.79

Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol Cell Biol (1996) 2.72

Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc Natl Acad Sci U S A (1996) 2.70

BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine. Antimicrob Agents Chemother (1991) 2.66

Ribavirin antagonizes the effect of azidothymidine on HIV replication. Science (1987) 2.51

Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon. Antimicrob Agents Chemother (1987) 2.47

Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands. J Theor Biol (1976) 2.42

Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc Natl Acad Sci U S A (1997) 2.42

A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems. J Biol Chem (1977) 2.32

Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge. J Virol (2001) 2.30

Determinants of compliance with iron supplementation: supplies, side effects, or psychology? Soc Sci Med (1994) 2.03

Daily versus weekly: how many iron pills do pregnant women need? Nutr Rev (1996) 1.99

Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol (2000) 1.97

Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro. J Infect Dis (1991) 1.93

Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120. AIDS Res Hum Retroviruses (1992) 1.85

Dieting behavior and eating attitudes in children. Pediatrics (1989) 1.81

Unusual electrocardiographic manifestation of pulmonary embolism. Am Heart J (1970) 1.74

Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. J Clin Invest (1987) 1.69

Contrasting effects of ibotenate lesions of the paraventricular nucleus and subparaventricular zone on sleep-wake cycle and temperature regulation. J Neurosci (2001) 1.62

Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies. J Natl Cancer Inst (1998) 1.60

Remifentanil for general anaesthesia: a systematic review. Anaesthesia (2007) 1.59

Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol (1988) 1.56

Transdermal scopolamine in the prevention of motion sickness at sea. Clin Pharmacol Ther (1981) 1.53

Use of cultured epidermal autografts and dermal allografts as skin replacement after burn injury. Lancet (1986) 1.53

Composite autologous-allogeneic skin replacement: development and clinical application. Plast Reconstr Surg (1987) 1.52

Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon. Antimicrob Agents Chemother (1986) 1.51

Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am J Med (1980) 1.50

A systematic review of prevention and intervention strategies for populations at high risk of engaging in violent behaviour: update 2002-8. Health Technol Assess (2012) 1.49

Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulins. J Virol (1998) 1.48

The binding of colchicine by sarcoma 180 cells. Biochem Pharmacol (1968) 1.43

A method of estimating curare-like activity on the isolated phrenic nerve diaphragm preparation of the rat. Br J Pharmacol Chemother (1947) 1.42

Cytochalasin B: effects on microfilaments and movement of melanin granules within melanocytes. Science (1972) 1.42

Design of antineoplastic agents on the basis of the "2-phenylnaphthalene-type" structural pattern. 2. Synthesis and biological activity studies of benzo]b]naphtho[2,3-d]furan-6,11-dione derivatives. J Med Chem (1993) 1.41

Strong in vitro synergy between the fusion inhibitor T-20 and the CXCR4 blocker AMD-3100. J Acquir Immune Defic Syndr (2000) 1.41

Isoflurane-induced vasodilation minimally increases cutaneous heat loss. Anesthesiology (1991) 1.40

Are platelet cytosolic free calcium, serotonin concentration and blood viscosity different between hypertensive and normotensive subjects? Cardiology (1994) 1.40

Unexpected cardiac arrest in patients after surgical correction of tetralogy of Fallot. Circulation (1975) 1.40

Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine. Antimicrob Agents Chemother (1992) 1.36

Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs. Am J Cardiol (1976) 1.35

Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors. Proc Natl Acad Sci U S A (1999) 1.33

The heroin epidemic in New York City: current status and prognoses. J Psychoactive Drugs (1998) 1.33

Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines. Cancer Res (1999) 1.31

Distinct roles of the molecular chaperone hsp90 in modulating dioxin receptor function via the basic helix-loop-helix and PAS domains. Mol Cell Biol (1995) 1.30

Properties of r mutants of bacteriophage T4 photodynamically induced in the presence of thiopyronin and psoralen. J Virol (1967) 1.28

Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade B. J Hum Virol (2001) 1.28

Delayed treatment with combinations of antiviral drugs in mice infected with herpes simplex virus and application of the median effect method of analysis. Antimicrob Agents Chemother (1986) 1.28

Unreliability of conventional electrocardiographic monitoring for arrhythmia detection in coronary care units. Am J Cardiol (1973) 1.28

Irinotecan is an active agent in untreated patients with metastatic colorectal cancer. J Clin Oncol (1996) 1.27

Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins. AIDS Res Hum Retroviruses (1997) 1.26

Lamivudine or stavudine in two- and three-drug combinations against human immunodeficiency virus type 1 replication in vitro. J Infect Dis (1996) 1.26

Heat shock protein hsp90 regulates dioxin receptor function in vivo. Proc Natl Acad Sci U S A (1995) 1.26

Perforin and granzyme A expression identifying cytolytic lymphocytes in rheumatoid arthritis. Proc Natl Acad Sci U S A (1992) 1.26

Three-drug synergistic inhibition of HIV-1 replication in vitro by zidovudine, recombinant soluble CD4, and recombinant interferon-alpha A. J Infect Dis (1990) 1.25

Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro. Antimicrob Agents Chemother (1992) 1.25

Incorporation of metabolites of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine into deoxyribonucleic acid of neoplastic and normal mammalian tissues. Biochem Pharmacol (1982) 1.24

Screening for behaviour problems in nurseries: the reliability and validity of the Preschool Behaviour Checklist. J Child Psychol Psychiatry (1986) 1.23

Different polypeptides form the intermediate filaments in bovine hoof and esophageal epithelium and in aortic endothelium. J Cell Biol (1981) 1.21

In vitro reconstitution of skin: fibroblasts facilitate keratinocyte growth and differentiation on acellular reticular dermis. J Invest Dermatol (1991) 1.21

Reevaluation of ichthyosis and hair shaft abnormalities. Arch Dermatol (1971) 1.20

Characteristics of mutations appearing spontaneously in extracellular particles of bacteriophage T4. Genetics (1967) 1.19

Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Mol Psychiatry (2009) 1.19

Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations. J Am Soc Nephrol (2001) 1.17

Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck. Cancer Res (1996) 1.17

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease. Neurobiol Aging (2007) 1.17

Influence of preadsorbed milk proteins on adhesion of Listeria monocytogenes to hydrophobic and hydrophilic silica surfaces. Appl Environ Microbiol (1994) 1.15

Cytochalasin B and pigment granule translocation. Cytochalasin B reverses and prevents pigment granule dispersion caused by dibutyryl cyclic AMP and theophylline in Rana pipiens Melanocytes. J Cell Biol (1972) 1.15

Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro. Transplantation (1991) 1.13

Traditional pharmacological treatments for spasticity. Part II: General and regional treatments. Muscle Nerve Suppl (1997) 1.13

The prevalence of behavioural problems in three types of preschool group. J Child Psychol Psychiatry (1986) 1.10

Purification of the DNA binding form of dioxin receptor. Role of the Arnt cofactor in regulation of dioxin receptor function. J Biol Chem (1994) 1.09

Electrocardiographic diagnosis of right ventricular infarction. Am J Med (1981) 1.09

Effects of adenosine on gabaergic synaptic inputs to identified ventrolateral preoptic neurons. Neuroscience (2003) 1.09

Distribution, metabolism, and excretion of 1-(2-fluoro-2-deoxy-beta-D- arabinofuranosyl)thymine and 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5- iodocytosine. Cancer Res (1983) 1.09

Experimental focal segmental glomerulosclerosis in mice. Nephron (1998) 1.08

Leg heat content continues to decrease during the core temperature plateau in humans anesthetized with isoflurane. Anesthesiology (1993) 1.07

A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia. Dement Geriatr Cogn Disord (2007) 1.07

Human immunodeficiency virus type 1 (HIV-1) inhibitory interactions between protease inhibitor Ro 31-8959 and zidovudine, 2',3'-dideoxycytidine, or recombinant interferon-alpha A against zidovudine-sensitive or -resistant HIV-1 in vitro. J Infect Dis (1992) 1.07

A rapid assay procedure for ATP:L-methionine adenosyltransferase. Biochim Biophys Acta (1972) 1.05

Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidine. Antimicrob Agents Chemother (1989) 1.05

Social isolation predicts re-hospitalization in a group of older American veterans enrolled in the UPBEAT Program. Unified Psychogeriatric Biopsychosocial Evaluation and Treatment. Int J Geriatr Psychiatry (2001) 1.04

Reconstitution of structure and cell function in human skin grafts derived from cryopreserved allogeneic dermis and autologous cultured keratinocytes. J Invest Dermatol (1988) 1.03

Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication. Antimicrob Agents Chemother (1996) 1.03

Interferon-alpha and 3'-azido-3'-deoxythymidine are highly synergistic in mice and prevent viremia after acute retrovirus exposure. J Acquir Immune Defic Syndr (1990) 1.02

Pharmacological disposition and metabolic fate of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mice and rats. Cancer Res (1981) 1.01

Suppression of Listeria monocytogenes colonization following adsorption of nisin onto silica surfaces. Appl Environ Microbiol (1995) 1.01

Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine. Antimicrob Agents Chemother (1991) 1.01

Retinoic acid causes premature desquamation of cells from confluent cultures of stratified squamous epithelia. J Invest Dermatol (1982) 1.01

Traditional pharmacological treatments for spasticity. Part I: Local treatments. Muscle Nerve Suppl (1997) 1.00

Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells. Cancer Res (1977) 1.00

Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine/rat cytochrome P450 2B1 and ganciclovir/herpes simplex virus thymidine kinase gene therapies. Cancer Res (1999) 1.00

Pupillary response to noxious stimulation during isoflurane and propofol anesthesia. Anesth Analg (1993) 0.99

Hydroa vacciniforme: diagnosis and therapy. Arch Dermatol (1982) 0.99